DE69534632T2 - Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit - Google Patents

Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit Download PDF

Info

Publication number
DE69534632T2
DE69534632T2 DE69534632T DE69534632T DE69534632T2 DE 69534632 T2 DE69534632 T2 DE 69534632T2 DE 69534632 T DE69534632 T DE 69534632T DE 69534632 T DE69534632 T DE 69534632T DE 69534632 T2 DE69534632 T2 DE 69534632T2
Authority
DE
Germany
Prior art keywords
clotrimazole
metabolites
treatment
sickle cell
cell disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69534632T
Other languages
English (en)
Other versions
DE69534632D1 (de
Inventor
Carlo Brugnara
Nader Rafai
Orah Platt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of DE69534632D1 publication Critical patent/DE69534632D1/de
Application granted granted Critical
Publication of DE69534632T2 publication Critical patent/DE69534632T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69534632T 1994-09-16 1995-09-15 Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit Expired - Fee Related DE69534632T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30787494A 1994-09-16 1994-09-16
PCT/US1995/011822 WO1996008242A2 (en) 1994-09-16 1995-09-15 Clotrimazole metabolites in the treatment of sickle cell disease

Publications (2)

Publication Number Publication Date
DE69534632D1 DE69534632D1 (de) 2005-12-29
DE69534632T2 true DE69534632T2 (de) 2006-06-14

Family

ID=23191532

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69534632T Expired - Fee Related DE69534632T2 (de) 1994-09-16 1995-09-15 Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit

Country Status (3)

Country Link
EP (1) EP0781128B1 (de)
DE (1) DE69534632T2 (de)
WO (1) WO1996008242A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7531573B2 (en) * 1994-09-16 2009-05-12 Children's Medical Center Corporation Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
US6028103A (en) * 1994-09-16 2000-02-22 Children's Medical Center Corporation Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
EP0918514B9 (de) * 1996-03-20 2006-07-05 President And Fellows Of Harvard College Triarylmethanverbindungen zur behandlung von krebs, aktinischer keratose und kaposisarkom
US5889038A (en) * 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
AU2962297A (en) * 1996-05-24 1998-01-05 Neurosearch A/S Phenyl derivatives useful as blockers of chloride channels
EP0906273B1 (de) 1996-05-24 2002-10-16 Neurosearch A/S Saure gruppen enthaltende phenylderivate, ihre herstellung und ihre verwendung als chloridkanalblocker
AU1224599A (en) 1997-11-14 1999-06-07 Neurosearch A/S Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
US6800658B2 (en) 1997-11-20 2004-10-05 Children's Medical Center Corporation Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
CA2310773A1 (en) * 1997-11-20 1999-06-03 Carlo Brugnara Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour
US6291449B1 (en) 1998-09-23 2001-09-18 Children's Medical Center Corporation Use of 11-phenyl-dibenzazepine compounds to treat diarrhea or scours
US6992079B2 (en) 1997-11-20 2006-01-31 President Fellows of Harvard College Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
EP1032385A1 (de) * 1997-11-20 2000-09-06 Children's Medical Center Corporation Verwendung von substituierten diphenyl indanone, indan und indol derivate zur behandlung oder vorbeugung von sichelzellanämie, entzüntlichen erkrankungen, die durch abnormale zellproliferation gekenzeichnet sind, diarrhöe und diarrhöe bei tieren
CA2310748C (en) 1997-11-20 2008-07-22 President And Fellows Of Harvard College Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
CN103102284A (zh) * 2011-11-09 2013-05-15 南京大学 4-三氟甲基-2，6-二硝基苯水杨醛肟类衍生物的制备及其在抗癌治疗药物中的应用
JP2023553161A (ja) 2020-12-11 2023-12-20 サンキン アイピー ビー．ブイ． 炎症性貧血の治療及び予防

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110615A (en) * 1980-02-06 1981-09-01 Yutaka Idota Treating and preventing agent against disease of respiratory organ of chicken
US5273992A (en) * 1992-11-02 1993-12-28 Beth Israel Hospital Assoc. Inc. Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ

Also Published As

Publication number Publication date
WO1996008242A3 (en) 1996-05-09
DE69534632D1 (de) 2005-12-29
EP0781128B1 (de) 2005-11-23
WO1996008242A2 (en) 1996-03-21
EP0781128A2 (de) 1997-07-02

Similar Documents

Publication Publication Date Title
ATE110556T1 (de) Verbesserungen bei der behandlung von zähnen.
ATE241977T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE69509650T2 (de) Behandlung atrialer fibrillationen
DE69503139D1 (de) Schuhwerk und dessen herstellung
DE69102451D1 (de) Herstellung und Verwendung von Farbstoffen.
ATE229815T1 (de) In vitro methoden und verwendung von pharmazeutische zusammensetzungen für die behandlung von innenohrhaarzellen
DE69008342D1 (de) Orthese für die Behandlung von Schienbeinverdrehungen bei Kindern.
DE69534632T2 (de) Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit
DE69101914D1 (de) Verzweigte fructo-oligosacchariden, verfahren zu ihrer herstellung und verwendung von diese enthaltenden mitteln.
DE69015788T2 (de) Thermistor und dessen herstellung.
DE69530486D1 (de) Behandlung von uteriner fibrosis
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69829763D1 (de) Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE69521595D1 (de) Optisch-aktives Benzothiepin-Derivate, ihre Herstellung und Verwendung
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
DE59812720D1 (de) Verwendung von phytostenol enthaltender wirkstoffmischungen zur herstellung von hypocholesterinämischen mitteln
DE68906245D1 (de) Therapeutisches mittel gegen aids.
DE68900867D1 (de) 1,5-benzothiazepinderivate, ihre herstellung und ihre verwendung in der behandlung von kardiovasculaeren stoerungen.
DE69101849D1 (de) Herstellung von Amiden.
DE69813354T2 (de) Mittel zur Behandlung von Herzkrankheiten
DE69703422D1 (de) Herstellung von Aminophenolen
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose
DE69000237D1 (de) Bleichfixier-regenerationssatz und verwendung davon in photographischer behandlung.
AU3634795A (en) Clotrimazole metabolites in the treatment of sickle cell disease

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee